Akoya BioSciences
AKYA
AKYA was delisted on the 7th of July, 2025.
59 hedge funds and large institutions have $29M invested in Akoya BioSciences in 2024 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 21 increasing their positions, 20 reducing their positions, and 16 closing their positions.
5% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 20
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5.15% less ownership
Funds ownership: 30.23% → 25.08% (-5.2%)
13% less funds holding
Funds holding: 68 → 59 (-9)
56% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 16
58% less capital invested
Capital invested by funds: $69.7M → $29M (-$40.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture
Dallas,
Texas
|
+$1.12M |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$507K |
| 3 |
BlackRock
New York
|
+$492K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$478K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$153K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$3.99M |
| 2 |
UIC
Uniplan Investment Counsel
Milwaukee,
Wisconsin
|
-$3.28M |
| 3 |
SAM
Silvercrest Asset Management
New York
|
-$2.72M |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$1.73M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$259K |
AKYA Hedge Fund Activity: Q2 2024 in Review
59 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Akoya BioSciences (AKYA) for Q2 2024, worth a combined $29M — down 58% from $69.7M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of AKYA and 7 opened new positions — a net loss of 9 holders — while 20 trimmed existing stakes and 21 added.
The largest buyer was Paragon Associates & Paragon Associates II Joint Venture, opening a new position worth an estimated $1.12M. The largest seller was Polar Capital Holdings, cutting an estimated $3.99M.
- 59 institutional investors held Akoya BioSciences (AKYA) as of Q2 2024, down from 68 in Q1 2024.
- Funds reported $29M of Akoya BioSciences stock for Q2 2024, down 58% quarter-over-quarter.
- 7 funds opened new Akoya BioSciences positions in Q2 2024 and 16 closed out, a net change of -9 holders.
- The largest Akoya BioSciences buyer in Q2 2024 was Paragon Associates & Paragon Associates II Joint Venture, an estimated $1.12M added.
- The largest Akoya BioSciences seller in Q2 2024 was Polar Capital Holdings, an estimated $3.99M sold.
Based on aggregated 13F filings for Q2 2024.